Lee R, Kumar R, Weaver A, Kim J, Raza A, Ong J
Diagnostics (Basel). 2025; 15(5).
PMID: 40075889
PMC: 11899542.
DOI: 10.3390/diagnostics15050643.
Maitiyaer M, Li P, Li H, Jiang D, Zhang J, Yang C
Front Pharmacol. 2025; 16:1484320.
PMID: 40046753
PMC: 11880234.
DOI: 10.3389/fphar.2025.1484320.
Ferreira A, Viveiros L, Faria R, Braganca F, Abreu A, Santos D
Int J Retina Vitreous. 2024; 10(1):94.
PMID: 39696716
PMC: 11657433.
DOI: 10.1186/s40942-024-00617-6.
Jafari Fesharaki M, Dehkordi N, Zakeri Z, Hosseinjani E, Dehkordi N
Clin Case Rep. 2024; 12(11):e9520.
PMID: 39493795
PMC: 11527729.
DOI: 10.1002/ccr3.9520.
Pawar Y, Thool A
Cureus. 2024; 16(8):e67078.
PMID: 39286691
PMC: 11405085.
DOI: 10.7759/cureus.67078.
Ocular fundus changes and association with systemic conditions in systemic lupus erythematosus.
Meng L, Wang Y, Yang Z, Lin S, Wang Y, Chen H
Front Immunol. 2024; 15:1395609.
PMID: 39091490
PMC: 11291259.
DOI: 10.3389/fimmu.2024.1395609.
The full range of ophthalmological clinical manifestations in systemic lupus erythematosus.
Kedia N, Theillac V, Paez-Escamilla M, Indermill C, Gallagher D, Adam R
Front Ophthalmol (Lausanne). 2024; 2:1055766.
PMID: 38983519
PMC: 11182226.
DOI: 10.3389/fopht.2022.1055766.
Lymph node targeting of cyclosporine ameliorates ocular manifestations in a mouse model of systemic lupus erythematosus (SLE) via PD-L1.
Ganugula R, Babalola K, Heyns I, Arora M, Agarwal S, Mohan C
Nano Today. 2024; 57.
PMID: 38911970
PMC: 11192230.
DOI: 10.1016/j.nantod.2024.102359.
Subclinical choroidal involvement in Systemic Lupus Erythematosus.
Ferreira A, Viveiros L, Faria R, Abreu A, Santos D, Furtado M
Graefes Arch Clin Exp Ophthalmol. 2024; 262(10):3313-3321.
PMID: 38780646
DOI: 10.1007/s00417-024-06526-6.
Sight-Threatening Unilateral Posterior Scleritis With Positive Atypical p-ANCA As Early Manifestation of Lupus Spectrum Disease.
Chew L, See W, Tan C, Mohamed S, Iqbal T, Ibrahim N
Cureus. 2024; 16(4):e58507.
PMID: 38765367
PMC: 11101982.
DOI: 10.7759/cureus.58507.
Aeromonas veronii-associated endogenous endophthalmitis: a case report.
Lin J, Zhong H, Chen Q, Cui L, Xu F, Tang F
J Med Case Rep. 2024; 18(1):171.
PMID: 38504363
PMC: 10953058.
DOI: 10.1186/s13256-024-04412-7.
Unveiling Ocular Manifestations in Systemic Lupus Erythematosus.
Musa M, Chukwuyem E, Ojo O, Topah E, Spadea L, Salati C
J Clin Med. 2024; 13(4).
PMID: 38398361
PMC: 10889738.
DOI: 10.3390/jcm13041047.
Quantitative assessment of retinal vasculature changes in systemic lupus erythematosus using wide-field OCTA and the correlation with disease activity.
Meng L, Chen L, Zhang C, Chen H, Yang J, Wang Y
Front Immunol. 2024; 15:1340224.
PMID: 38348025
PMC: 10859513.
DOI: 10.3389/fimmu.2024.1340224.
Scleral changes in systemic lupus erythematosus patients using swept source optical coherence tomography.
Chen L, Meng L, Sun L, Chen Y
Front Immunol. 2023; 14:1278893.
PMID: 38022606
PMC: 10656698.
DOI: 10.3389/fimmu.2023.1278893.
Pediatric Lupus Retinopathy: A Rare Manifestation of a Grave Systemic Disorder.
Parakh S, Bhatt V, Das S, Chaturvedi A, Luthra G, Katoch D
Cureus. 2023; 15(10):e46616.
PMID: 37937017
PMC: 10626398.
DOI: 10.7759/cureus.46616.
An Orbital Pseudotumor Secondary to Systemic Lupus Erythematosus: A Case Report.
AlQahtani E, Albalawi Y, Altwaijri N, Alqahtani Jr L, Alshail S
Cureus. 2023; 15(9):e44994.
PMID: 37829992
PMC: 10565082.
DOI: 10.7759/cureus.44994.
Subclinical retinopathy in systemic lupus erythematosus patients - optical coherence tomography study.
Mimier-Janczak M, Kaczmarek D, Proc K, Misiuk-Hojlo M, Kaczmarek R
Reumatologia. 2023; 61(3):161-168.
PMID: 37522138
PMC: 10373166.
DOI: 10.5114/reum/166296.
Unusual Cause of Vision Loss in a Case of Lupus.
Padhan P, Das M, Pradhan A, Maikap D
Mediterr J Rheumatol. 2023; 33(4):455-458.
PMID: 37034364
PMC: 10075383.
DOI: 10.31138/mjr.33.4.455.
Systemic Lupus Erythematosus and Risk of Dry Eye Disease and Corneal Surface Damage: A Population-Based Cohort Study.
Tseng C, Tai Y, Hong C, Dai Y, Chen T, Cherng Y
Int J Environ Res Public Health. 2023; 20(5).
PMID: 36900786
PMC: 10001508.
DOI: 10.3390/ijerph20053776.
Systemic Lupus Erythematosus May Be a Risk Factor for Antimalarial-Induced Retinopathy Compared With Other Rheumatologic Diseases.
Liu H, Cramarossa G, Pope J
ACR Open Rheumatol. 2023; 5(4):173-179.
PMID: 36787153
PMC: 10100695.
DOI: 10.1002/acr2.11531.